Regulatory delays could hinder Mind Medicine's patient access and market entry. Read why we are initiating coverage on MNMD ...

Chico, Vice President and Global Head of Oncology Therapeutic Expertise at Fortrea, shares how scientific advances, AI tools and flexible CRO models are accelerating oncology trials and improving ...

How Ardena’s integrated services, nanomedicine expertise, and North American expansion are advancing drug development for ...

Sarfaraz K. Niazi, PhD, shares his latest citizen's petition to the FDA, calling on the agency to waive clinical efficacy ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

In an interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven pathway that could be leveraged by rare disease therapies while saying that ...

Most consumers want to understand the full financial picture before using the antifungal nail treatment called Jublia. This ...